Exosens share climbs nearly 2% and posts +12.5% over three months
The Bordeaux-based optronics company's stock regained ground on Tuesday, advancing against the grain of a nearly stable SBF 120. The movement extends a consolidation phase following last week's turbulence, which had seen the stock among the index's sharpest declines.
A rebound that consolidates the position above the three moving averages
Exosens is trading at 60.95 € during the session, gaining 1.75% compared to the previous close at 59.90 €. This rebound places the stock among the best performers of the SBF 120, in an index showing only -0.06% at the same time. The technical configuration remains favorable: the price is above its three moving averages simultaneously, with a gap of nearly 5% compared to the 20-day MA at 58.13 €, 1.43% above the 50-day MA at 60.09 €, and 2.52% above the 200-day MA at 59.45 €.
The RSI at 52 reflects a neutral configuration, without overbought signal, which leaves room before reaching the resistance identified at 64.50 €. Over the last three months, the stock shows +12.56%, solid progress when compared to the support at 54.15 €, which remains significantly below the current price.
The revision of 2026 targets still in the background of upward momentum
Tuesday's movement is part of a sequence that has profoundly reconfigured the stock since mid-September. the revision of annual targets, published on September 17, had propelled the stock by nearly 10% in a single session, before it was subsequently caught up by several days of correction. Exosens was banking on approximately 20% growth in its revenue, with sales up to 570 M€, and approximately 25% growth in its adjusted EBITDA for 2026. In the wake of this, Bernstein had raised its target to 74 € on September 23, representing potential upside of approximately 21% from the current price. The publication of nine-month results, expected on October 27, 2026, will be the next concrete milestone to assess the group's actual trajectory relative to these revised ambitions.
